Yugang Wang

2.3k citations
43 papers · 1.8k indexed · 1 hit paper · h-index 24
Topics
Cancer-related molecular mechanisms research (8 papers)Circular RNAs in diseases (6 papers)MicroRNA in disease regulation (5 papers)

In The Last Decade

Yugang Wang

42 papers receiving 1.8k citations

Hit Papers

Targeting ferroptosis suppresses osteocyte glucolipotoxic...2022202620232024202250100150

Peers

Yugang Wang
Comparison fields: 5 of 102
  • Molecular Biology 1.1k
  • Cancer Research 680
  • Oncology 307
  • Immunology 231
  • Epidemiology 209
Replace Xiaoyan Xin with:
Xiaoyan Xin China
Bin Zhu China
Fei Long China
Feng Jiang China
Xiaojun Zhang China
Quintin Pan United States
Xingwu Wang China
Jiaxing Zhang China
Jong Kook Park South Korea
Yugang Wang relative to Xiaoyan Xin China Xiaoyan Xin's profile →
Citations per field
00.5×
Xiaoyan Xin · 1×
Citations per year

Countries citing papers authored by Yugang Wang

Since Specialization
Citations

This map shows the geographic impact of Yugang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yugang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yugang Wang more than expected).

Fields of papers citing papers by Yugang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yugang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yugang Wang. The network helps show where Yugang Wang may publish in the future.

Co-authorship network of co-authors of Yugang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yugang Wang. A scholar is included among the top collaborators of Yugang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yugang Wang. Yugang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 4
4 8
5 34
6 16
7 142
8 97
9 19
10 43
11 18
12 19
13 60
14 34
15 32
16 16
17 36
18 15
19 160
20
Study on the bionomics of Cercospora destructiva Rav.
1

About Yugang Wang

Yugang Wang is a scholar working on Cancer Research, Hepatology and Oncology, having authored 43 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (680 citations), Molecular Biology (1.1k citations) and Oncology (307 citations). Yugang Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Min Shi, Jiali Ma, Wenying Meng, Jue Wei, Tingting Tang, Qiong Wu, Bo Zhai, Shihao Xiang, Peter J. Polverini and Jacques E. Nör. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026